🟢 Jasper Therapeutics is trading 5% up in after-hours trading with no confirmed company-specific catalyst

Jasper Therapeutics is trading 5.24% up at $0.60 after closing at $0.57 on September 15, with no new company-specific catalyst identified.

• No new earnings, regulatory decision, financing, merger, or clinical announcement was identified for September 15.
• Jasper Therapeutics is scheduled to present at the H.C. Wainwright Global Investment Conference on September 16, which may be supporting speculative interest, but no source explicitly links it to the after-hours move.